https://www.selleckchem.com/pr....oducts/trometamol.ht
5 kg/m , there was no significant difference between 2 procedures 0.57 (95% CI 0.43-0.71) for SG versus 0.66 (95% CI 0.62-0.7 for RYGB. The cost-effectiveness ratios of SG and RYGB were 244.58 and 276.97 dollars per QALY, respectively. For patients with diabetes duration 5 years, RYGB was the optimal choice with regard to achieving complete diabetes remission at 1 year after surgery. However, for patients with diabetes duration ≤ 5 years and BMI ≥ 35.5 kg/m , SG appeared to provide a cost-effective choice. 5 years, RYGB was th
Like
Comment
Share
